Regeneron Pharmaceuticals
REGN
REGN
1,377 hedge funds and large institutions have $96.1B invested in Regeneron Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 140 funds opening new positions, 535 increasing their positions, 457 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.4% less ownership
Funds ownership: 86.77% → 85.36% (-1.4%)
21% less funds holding in top 10
Funds holding in top 10: 29 → 23 (-6)
22% less call options, than puts
Call options by funds: $1.41B | Put options by funds: $1.8B
Holders
1,377
Holding in Top 10
23
Calls
$1.41B
Puts
$1.8B
Top Buyers
| 1 | +$360M | |
| 2 | +$343M | |
| 3 | +$257M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$223M |
| 5 |
WorldQuant Millennium Advisors
New York
|
+$127M |
Top Sellers
| 1 | -$828M | |
| 2 | -$653M | |
| 3 | -$358M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$301M |
| 5 |
Morgan Stanley
New York
|
-$164M |